These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 893175)

  • 41. [Dosimetry in contact therapy with 252Cf irradiation].
    Elisiutin GP; Komar VIa
    Med Radiol (Mosk); 1977 Oct; 22(10):54-9. PubMed ID: 916842
    [No Abstract]   [Full Text] [Related]  

  • 42. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Several radiobiological aspects of tumor treatment with 252Cf radiation].
    Lychev VA; Iuzhakov VV; Savina NP
    Med Radiol (Mosk); 1979 Sep; 24(9):3-9. PubMed ID: 574182
    [No Abstract]   [Full Text] [Related]  

  • 44. [Reoxygenation of tumors of the uterine cervix during combined radiotherapy using low dose gamma-neutron irradiation with californium-252].
    Tacev T; Rasovská O; Strnad V; Krystof V; Prokes B; Vacek A
    Cesk Radiol; 1989 Mar; 43(2):125-35. PubMed ID: 2731302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Basic principles of percutaneous radiotherapy in cervical lymph node metastases].
    Scherer E; Rassow J
    Strahlentherapie; 1971 May; 141(5):523-30. PubMed ID: 4996725
    [No Abstract]   [Full Text] [Related]  

  • 46. [Patterns of the formation of a dosage field in arranging 252Cf and 60Co sources in a single plane].
    Ivanov VN; Vtiurin BM; Ivanova LF; Kondzhariia IuR
    Med Radiol (Mosk); 1983 Mar; 28(3):38-42. PubMed ID: 6835057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neutron brachytherapy is better than conventional radiotherapy in advanced cervical cancer.
    Maruyama Y; Kryscio R; van Nagell JR; Yoneda J; Donaldson E; Hanson M; Beach JL; Feola JM; Martin A; Parker C
    Lancet; 1985 May; 1(8438):1120-2. PubMed ID: 2860334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of radiophotoluminescent glass for dosimetry of Cf-252 neutron and gamma radiation].
    Elisiutin GP; Komar VIa; Fadeeva MA
    Med Radiol (Mosk); 1982 Feb; 27(2):69-72. PubMed ID: 7070246
    [No Abstract]   [Full Text] [Related]  

  • 49. [Immediate and early results with the contact irradiation of tumors using 252Cf sources].
    Vtiurin BM; Galantseva GF; Medvedev VS; Abdulkadyrov SA
    Radiobiol Radiother (Berl); 1983; 24(2):157-63. PubMed ID: 6867298
    [No Abstract]   [Full Text] [Related]  

  • 50. [The technology of preparation and experience in the clinical use of 252Cf sources].
    Vtiurin BM; Karelin EA; Ivanov VN; Karasev VI; Berkutov VL; Ivanova LF; Medvedev VS
    Med Radiol (Mosk); 1989 Sep; 34(9):60-4. PubMed ID: 2796645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Microdosimetric characteristics of the neutron spectrum of 252Cf fission and of the P-2 and B-3 beams from the BP-10 reactor].
    Pitkevich VA; Videnskiĭ VG
    Med Radiol (Mosk); 1978 Oct; 23(10):47-52. PubMed ID: 703547
    [No Abstract]   [Full Text] [Related]  

  • 52. Cf-252 neutron brachytherapy of short duration for bulky neck tumors.
    Maruyama Y; Beach JL
    Int J Radiat Oncol Biol Phys; 1986 May; 12(5):761-770. PubMed ID: 3011711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Oxygen enhancement ratio (OER) and therapeutic gain factor (GF) for low-dose irradiation with californium-252].
    Wambersie A; Van Dam J; Octave-Prignot M; Dutreix A
    C R Seances Soc Biol Fil; 1982; 176(3):429-34. PubMed ID: 6215110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
    Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical study of relative biological effectiveness for cervical carcinoma treated by 252Cf neutrons and assessed by histological tumour eradication.
    Maruyama Y; Feola JM; Wierzbicki J; van Nagell JR; Powell D; Yoneda J
    Br J Radiol; 1990 Apr; 63(748):270-7. PubMed ID: 2112036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dosage fields of the "ANET-B" apparatus with 252Cf].
    Sevast'ianov AI; Drygin VN; Elisiutin GP; Karpova IA; Komar VIa
    Med Radiol (Mosk); 1983 May; 28(5):24-9. PubMed ID: 6855490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase I-II clinical trial of Californium-252. Treatment of stage IB carcinoma of the cervix.
    Maruyama Y; VanNagell JR; Yoneda J; Donaldson E; Gallion H; Rowley K; Kryscio R; Beach JL
    Cancer; 1987 Apr; 59(8):1500-5. PubMed ID: 3028603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of brachytherapy in the management of recurrent carcinoma of the head and neck.
    Nag SK; Vider M; Neely CL; Pritchard A; Tai DL
    J Tenn Med Assoc; 1982 May; 75(5):321-4. PubMed ID: 7132333
    [No Abstract]   [Full Text] [Related]  

  • 59. Dose-rate effects for various dose rates of 252Cf radiation on HeLa cells in culture.
    Fairchild RG; Drew RM; Atkins HL
    Radiology; 1970 Jul; 96(1):171-4. PubMed ID: 5463284
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effectiveness of the radiosensitizer cisplatin. A pilot study].
    Klima A; Szepesi S
    Laryngol Rhinol Otol (Stuttg); 1987 Sep; 66(9):457-9. PubMed ID: 3683038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.